// App-Quantinova.ai

: Effect of Daratumumab on Stem Cell Mobilization and Engraftment Kinetics Post Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma

Researchers

Presenter

  • Samir Oza

Principal Investigators

  • Ronit Slotky

  • Pranay Vissa

  • Pooja Phull

  • Sukhdeep Kaur

  • Hyung C. Suh

  • Michele L. Donato

  • Scott D. Rowley

  • Noa Biran

  • David H. Vesole

  • David Siegel

  • Harsh Parmar

Medical Centers

  • Hackensack Meridian School of Medicine, Nutley, NJ

  • John Theurer Cancer Center, Division of Multiple Myeloma, Hackensack University Medical Center, Hackensack, NJ

  • John Theurer Cancer Center, Hackensack University Medical Center, Hackensack, NJ

  • Myeloma Division, John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, NJ

  • Division of Multiple Myeloma, John Theurer Cancer Center, Hackensack Meridian Health Network, Hackensack University Medical Center, Hackensack, NJ

  • Hackensack Meridian Health John Theurer Cancer Center, Hackensack, NJ

  • Stem Cell Transplantation and Cellular Therapy Program, John Theurer Cancer Center, Hackensack Meridian Health, Hackensack, NJ

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Multiple Myeloma

Biomarkers

  • Cluster of Differentiation 34

  • Granulocyte colony-stimulating factor

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • daratumumab Intravenous

  • Plerixafor

  • Etoposide

  • Etoposide phosphate

  • Melphalan

  • Filgrastim

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved